AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT FOR INVESTORSRegistration Rights Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
THIS AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT (this “Agreement”) is made as of May 16, 2019, by and among TFF Pharmaceuticals, Inc., a Delaware corporation (“Company”), and the persons listed on Schedule A hereto, referred to individually as the “Stockholder” and collectively as the “Stockholders”.
CONSULTING AGREEMENTConsulting Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
THIS Consulting Agreement (this “Agreement”), is made by and between TFF Pharmaceuticals, Inc, a Delaware Corporation with its principal place of business at 2801 Via Fortuna, Suite 425, Austin, Texas 78746 (“Company”), and Glenn Mattes, an individual having an address of 4524 Everview Drive, Doylestown, PA 18902 (“Consultant”). Company and Consultant shall, at times throughout this Agreement, be referred to individually as a “Party” and collectively as the “Parties”.
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”), dated as of March 13, 2018 (the “Effective Date”), is by and among TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and the investors listed on the Schedule of Buyers, attached hereto as Exhibit A (individually, a “Buyer” and collectively, the “Buyers”).
Patent License Agreement Agreement No. PM1504101Patent License Agreement Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Patent License Agreement is between the Licensor and the Licensee identified below (collectively, “Parties”, or singly, “Party”).
contribution AND SUBSCRIPTION AGREEMENTContribution and Subscription Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Delaware
THIS CONTRIBUTION AND SUBSCRIPTION AGREEMENT (this “Agreement”) is made as of this 24th day of January, 2018 by and between Lung Therapeutics, Inc., a Texas corporation (the “Contributor”), and TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”).
AMENDMENT #1 TO PATENT LICENSE AGREEMENTPatent License Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations
This Amendment #1 to the Patent License Agreement (“Amendment”) is made and entered into as of November 30, 2018 (“Amendment Effective Date”) by and between TFF Pharmaceuticals, Inc. (“Licensee”) and The University of Texas at Austin, on behalf of the Board of Regents of the University of Texas System (“Licensor”), an agency of the State of Texas.
EMPLOYMENT AGREEMENTEmployment Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • Texas
This Employment Agreement (this “Agreement”) is made and entered into as of February 15, 2019 (the “Effective Date”) by and between TFF Pharmaceuticals., Inc., a Delaware corporation (the “Company”), and Kirk Coleman, an individual (“Executive”).
TFF PHARMACEUTICALS, Inc. EXECUTIVE EMPLOYMENT AGREEMENTExecutive Employment Agreement • August 20th, 2019 • TFF Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
This Executive Employment Agreement (this “Agreement”) is entered into as of December 20, 2018, by and between TFF Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Glenn Mattes (“Executive”).
